Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patients
•Largest study of rituximab in MOG-IgG-associated disorder, includes both adults and children.•Rituximab reduced relapse rates in MOG-IgG-associated disorder by 37%.•Compared to similar studies in AQP4-IgG-associated NMOSD, the efficacy seems lower.•Some patients relapsed despite apparent circulatin...
Saved in:
| Published in: | Multiple sclerosis and related disorders Vol. 44; p. 102251 |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
Netherlands
Elsevier B.V
01.09.2020
Elsevier |
| Subjects: | |
| ISSN: | 2211-0348, 2211-0356, 2211-0356, 2211-0348 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!